Literature DB >> 34035760

Update on Fecal Microbiota Transplantation for the Treatment of Inflammatory Bowel Disease.

Jessica R Allegretti1.   

Abstract

Entities:  

Year:  2021        PMID： 34035760      PMCID： PMC8132680     

Source DB:  PubMed          Journal:  Gastroenterol Hepatol (N Y)        ISSN： 1554-7914


× No keyword cloud information.
  9 in total

1.  Findings From a Randomized Controlled Trial of Fecal Transplantation for Patients With Ulcerative Colitis.

Authors:  Noortje G Rossen; Susana Fuentes; Mirjam J van der Spek; Jan G Tijssen; Jorn H A Hartman; Ann Duflou; Mark Löwenberg; Gijs R van den Brink; Elisabeth M H Mathus-Vliegen; Willem M de Vos; Erwin G Zoetendal; Geert R D'Haens; Cyriel Y Ponsioen
Journal:  Gastroenterology       Date:  2015-03-30       Impact factor: 22.682

2.  Multidonor intensive faecal microbiota transplantation for active ulcerative colitis: a randomised placebo-controlled trial.

Authors:  Sudarshan Paramsothy; Michael A Kamm; Nadeem O Kaakoush; Alissa J Walsh; Johan van den Bogaerde; Douglas Samuel; Rupert W L Leong; Susan Connor; Watson Ng; Ramesh Paramsothy; Wei Xuan; Enmoore Lin; Hazel M Mitchell; Thomas J Borody
Journal:  Lancet       Date:  2017-02-15       Impact factor: 79.321

3.  Outcomes of Fecal Microbiota Transplantation in Patients With Inflammatory Bowel Diseases and Recurrent Clostridioides difficile Infection.

Authors:  Jessica R Allegretti; Colleen R Kelly; Ari Grinspan; Benjamin H Mullish; Zain Kassam; Monika Fischer
Journal:  Gastroenterology       Date:  2020-07-30       Impact factor: 22.682

4.  Fecal Microbiota Transplantation Induces Remission in Patients With Active Ulcerative Colitis in a Randomized Controlled Trial.

Authors:  Paul Moayyedi; Michael G Surette; Peter T Kim; Josie Libertucci; Melanie Wolfe; Catherine Onischi; David Armstrong; John K Marshall; Zain Kassam; Walter Reinisch; Christine H Lee
Journal:  Gastroenterology       Date:  2015-04-07       Impact factor: 22.682

Review 5.  The risk of inflammatory bowel disease flares after fecal microbiota transplantation: Systematic review and meta-analysis.

Authors:  Taha Qazi; Thelina Amaratunga; Edward L Barnes; Monika Fischer; Zain Kassam; Jessica R Allegretti
Journal:  Gut Microbes       Date:  2017-09-12

Review 6.  The Current Landscape and Lessons from Fecal Microbiota Transplantation for Inflammatory Bowel Disease: Past, Present, and Future.

Authors:  Jessica Allegretti; Lindsay M Eysenbach; Najwa El-Nachef; Monika Fischer; Colleen Kelly; Zain Kassam
Journal:  Inflamm Bowel Dis       Date:  2017-10       Impact factor: 5.325

Review 7.  Fecal transplantation for ulcerative colitis: current evidence and future applications.

Authors:  Loris R Lopetuso; Gianluca Ianiro; Jessica R Allegretti; Stefano Bibbò; Antonio Gasbarrini; Franco Scaldaferri; Giovanni Cammarota
Journal:  Expert Opin Biol Ther       Date:  2020-02-26       Impact factor: 4.388

Review 8.  Insights into the role of fecal microbiota transplantation for the treatment of inflammatory bowel disease.

Authors:  Alexander N Levy; Jessica R Allegretti
Journal:  Therap Adv Gastroenterol       Date:  2019-03-14       Impact factor: 4.409

9.  Inflammatory Bowel Disease Outcomes Following Fecal Microbiota Transplantation for Recurrent C. difficile Infection.

Authors:  Jessica R Allegretti; Colleen R Kelly; Ari Grinspan; Benjamin H Mullish; Jonathan Hurtado; Madeline Carrellas; Jenna Marcus; Julian R Marchesi; Julie A K McDonald; Ylaine Gerardin; Michael Silverstein; Alexandros Pechlivanis; Grace F Barker; Jesus Miguens Blanco; James L Alexander; Kate I Gallagher; Will Pettee; Emmalee Phelps; Sara Nemes; Sashidhar V Sagi; Matthew Bohm; Zain Kassam; Monika Fischer
Journal:  Inflamm Bowel Dis       Date:  2021-08-19       Impact factor: 5.325
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.